Kin Yip Leung
Director/Board Member en NOVOCURE LIMITED .
Fortuna: 1 M $ al 31/03/2024
Perfil
Kin Yip Leung is currently the Vice Chairman at NovoCure Ltd.
He previously worked as an Independent Director at Curia Global, Inc. from 2010 to 2016, Director at Delcath Systems, Inc. in 2014, Director at NanoMed Pharmaceuticals, Inc., Independent Non-Executive Director at Pernix Therapeutics Holdings, Inc. from 2016 to 2019, Principal at Bristol Myers Squibb Co. from 1990 to 1999, EVP, President-Oncology & Diabetes Business at OSI Pharmaceuticals, Inc. from 2003 to 2010, and Group Vice President-Global Prescription Business at Pharmacia Corp.
from 1999 to 2003.
Mr. Leung is a member of C-Change.
He received his undergraduate degree from The University of Texas at Austin and his graduate degree from the University of Wisconsin.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NOVOCURE LTD.
0.07% | 07/06/2023 | 79 139 ( 0.07% ) | 1 M $ | 31/03/2024 |
Cargos activos de Kin Yip Leung
| Empresas | Cargo | Inicio |
|---|---|---|
| NOVOCURE LIMITED | Director/Board Member | 05/08/2011 |
Antiguos cargos conocidos de Kin Yip Leung.
| Empresas | Cargo | Fin |
|---|---|---|
| PERNIX THERAPEUTICS HOLDINGS INC | Director/Board Member | 09/05/2019 |
| ALBANY MOLECULAR RESEARCH, INC. | Director/Board Member | 04/02/2016 |
| DELCATH SYSTEMS, INC. | Chairman | 15/09/2014 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2010 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 01/04/2003 |
Formación de Kin Yip Leung.
| The University of Texas at Austin | Undergraduate Degree |
| University of Wisconsin | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| DELCATH SYSTEMS, INC. | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Empresas privadas | 6 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Curia Global, Inc.
 Curia Global, Inc. Miscellaneous Commercial ServicesCommercial Services Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Commercial Services |
NanoMed Pharmaceuticals, Inc.
 NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services NanoMed Pharmaceuticals, Inc. developed therapeutic and diagnostic products. The company was founded by Michael Jay, Stephen Benoit and Russell J. Mumper in 2000 and was headquartered in Kalamazoo, MI. | Commercial Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
| C-Change | |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Kin Yip Leung
